COPD phenotypes not linked to increased risk of coronary heart disease
C. Svendsen (Bergen, Norway), T. Eagan (Bergen, Norway), P. Bakke (Bergen, Norway), R. Nielsen (Bergen, Norway), E. Nordeide (Bergen, Norway), V. Hodneland (Stord, Norway), K. Ostridge (Southampton, United Kingdom), T. Larsen (Bergen, Norway), K. Kuiper (Bergen, Norway)
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Session: Comorbidities galore in respiratory patients
Session type: Oral Presentation
Number: 289
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Svendsen (Bergen, Norway), T. Eagan (Bergen, Norway), P. Bakke (Bergen, Norway), R. Nielsen (Bergen, Norway), E. Nordeide (Bergen, Norway), V. Hodneland (Stord, Norway), K. Ostridge (Southampton, United Kingdom), T. Larsen (Bergen, Norway), K. Kuiper (Bergen, Norway). COPD phenotypes not linked to increased risk of coronary heart disease. 289
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Cardiointervalography in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005
COPD is associated with an increased risk of peripheral artery disease and mortality Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018 Year: 2018
Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010
Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002
OSA as a cause of cardiovascular disease, including heart failure Source: ERS Conference Year: 2015
Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD Year: 2018
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Assessment of pulmonary function stratifies global coronary heart disease risk Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology Year: 2009
Assessment of cardiovascular comorbidity Source: Eur Respir Mon 2013; 59: 28-49 Year: 2013
Increased risk of peripheral arterial disease in individuals with COPD Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017
Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD) Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Genetically elevated ace activity is not associated with ischaemic heart disease, hypertension, or physical activity in COPD Source: Annual Congress 2009 - Risk factors for COPD Year: 2009
Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure Source: International Congress 2019 – More and more COPD Year: 2019
Predictors of coronary heart disease in patients with COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015
Increased prevalence of obstructive airways disease (OAD) in patients with ischemic heart disease (IHD) and hypertension (HT) Source: Eur Respir J 2007; 30: Suppl. 51, 122s Year: 2007
Lung diffusion capacity is reduced in patients with coronary artery disease and no signs of heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 406s Year: 2006
Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD) Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019
The association of respiratory health and cardiovascular risk with structural brain disease in patients with COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018
Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications Source: International Congress 2015 – COPD: notable points Year: 2015